Multifactorial drug-resistance phenomenon in acute leukemias: Impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcome

Leukemia and Lymphoma

Volumn 23, Issue 5-6, 1996, Pages 567-576

  Goasguen, Jean E ^a,b   Lamy, Thierry ^a   Bergeron, Christophe ^a   Sunaram, Béatrice L Y ^a   Mordelet, Erwan ^a   Gorre, Gilles ^a   Dossot, Jean Marc ^a   Le Gall, Edouard ^a   Grosbois, Bernard ^a   Le Prisé, Pierre Yves ^a   Fauchet, Renée ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

^b SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Acute leukemias; GST; LRP56; MDR; MT; P170

Indexed keywords

ANTINEOPLASTIC AGENT; CARRIER PROTEIN; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; METALLOTHIONEIN;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHILD; DRUG DETOXIFICATION; DRUG TRANSPORT; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEUKEMIA REMISSION; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; MYELOID LEUKEMIA; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 12644252020     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054866     Document Type: Article

References (47)

1. Roninson, I. B. (1992) The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. Biochem. Pharmacol , 43, 95.
2. Roninson, I B. (ed). (1991) Molecular and cellular biology of multidrug resistance in tumor cells. New York, NY, Plenum.
3. van der Valk, P., van Kalken, C. K., Ketelaars, H., Broxterman, H. J , Scheffer, G., Kuiper, C. M., Tsuruo, T., Lankelma, J., Meijer, C. J., Pinedo, H., Scheper, R. (1990) Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Ann. Oncol., 1, 56.
4. Arceci, R. J. (1993) Clinical signification of P-glycoprotein in multidrug resistance malignancies. Blood, 81, 2215.
5. Goldstein, L. J., Galski, H., Fojo, A., Willingham, M., Lai, S. L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., Lieber, M., Cossman, I., Gottesman, M., Pastan, I. (1989) Expression of a multidrug gene in human cancers. J. Natl. Cancer Inst., 81, 116.
6. Schneider, J., Bak, M., Efferth, T., Kaufin, M., Mattern, J., Volm, M. (1989) P-glycoprotein expression in treated and untreated human breast cancer. Br. J. Cancer, 60, 815.
7. Chan, H., Thornet, P., Haddad, G., Ling, V. (1990) Immunohistochemical detection of P-giycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol., 8, 689.
8. Bourhis, J., Benard, J., Hartmann, O., Boccon, G. L., Lemerle, J., Riou, G. (1989) Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. J. Natl. Cancer Inst , 81, 1401.
9. Sato, H., Gottesman, M. M., Goldstein, L. J., Pastan, I., Block, A. M., Sandberg, A A., Preisler, H. D (1990) Expression of the multidrug resistance gene in Myeloid leukemias. Leuk. Res., 14, 11.
10. Sato, H., Preisler, H., Day, R., Raza, A., Larson, R., Browman, G., Goldberg, J., Vogler, R., Grunwald, H, Gottlieb, A., Bennett, I., Gottesman, M., Pastan, I. (1990) MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukemia. Br. J. Haematol., 75, 340.
11. Musto, P., Melillo, L., Lombardi, G., Matera, R., Di Giorgio, G., Carotenuto, M. (1991) High risk of early resistant relapse for leukaemic patients with presence of multidrug resistance associated P-glycoprotein positive cells in complete remission. Br. J. Haematol., 77, 50.
12. Pirker, R., Wallner, J., Geissler, K., Linkesch, W., Mass, O. A., Bettelheim, P., Hopjner, M., Scherrer, R., Valent, P., Havelec, L., Ludwig, H., Lechner, K. (1991) MDR1 gene expression and treatment outcome in acute myeloid leukemia. J. Natl. Cancer Inst., 83, 708.
13. Campos, L., Guoytat, D., Archimbaud, E., Calmard, O. P., Tsuruo, T, Troncy, J., Treille, D., Fiere, D. (1992) Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood, 79, 473.
14. Marie, J.-P., Zittoun, R., Sikic, B. I. (1991) Multidrug resistance (mdr1) gene expression in adult acute leukemias Correlations with treatment outcome and in vitro drug sensitivity. Blood, 78, 586.
15. Rortenberg, M. L., Mickley, L A., Cole, D. E., Balis, F M , Tsuruo, T., Poplack, D. G , Fojo A. T. (1989) Expression of the mdr4/P-170 gene in patients with acute lymphoblastic leukemia. Blood, 74, 1388.
16. Pieters, R., Hongo, T., Loonen, A. H., Huismans, D. R., Browterman, H J., Halhlen, K., Veerman, A. J P. (1992) Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukemia. Br J. Cancer, 65, 691.
17. Goasguen, J. E., Dossot, J.-M., Fardel, O., Le Mee, F , Le Gall, E., Leblay, R., Le Prise, P. Y., Chaperon, J., Fauchet, R. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood, 81, 2394.
18. Beck, W. T., Curtain, M. C., Danks, M. K., Fested, R. L., Sara, A. R., Wolverton, J S., Suttle, D. P., Trent, J. M. (1987) Pharmacological, molecular and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells. Cancer Res., 47, 5455.
19. Baas, F., Jongsma, A. P , Broxterman, H. J., Areeci, R. J., Housman, D., Scheffer, G. L., Reithorst, A., van Groenigen, M., Nieuwint, A. W., Joenje, H. (1990) Non-P-glycoprotein mediated mechanism for multidrug resitance precedes P-glycoprotein expression during during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res., 50, 5392.
20. Kramer, R. A., Zakher, J., Kim, G. (1988) Role of the glutathione redox cyle in acquired and de novo multidrug resistance. Science, 241, 694.
21. Lutzky, J., Astor, M. B., Taub, R. N., Baker, M. A., Bhalla, K., Gervasoni, J E. Jr, Rosado, M., Stewart, V., Krishna, S., Hindenburg, A. (1989) Role of glutathione and dependant enzymes in anthracycline-resistant HL60/AR cells. Cancer Research, 49, 4120
22. Nakagawa, K., Saijo, N., Tsuchida, S., Sakai, M., Tsunokawa, Y., Yokota, J., Muramatsu, M., Saw, K., Terada, M., Tew, K. D. (1990) Glutathione S-transferase n as a determinant of drug resistance in transfectant cell lines. J. Biol. Chem., 265, 4296.
23. Tidefelt, U., Elmhorm-Rosenborg, A., Paul, C., Hao, X. Y., Mannervick, B., Erickson, L. C. (1992) Expression of glutathione transferase π as a predictor for treatment results at different stages of acute nonlymphoblastique leukemia. Cancer Reasearch, 52, 3281.
24. Bakka, A., Entiresen, L., Johnsen, A. B. S., Edminson, P. D., Rugstad, H. E. (1981) Resistance against cis-dichlorodiamineplatinium in cultered cells with a high content of metallothionein. Toxicol. Appl. Pharmacol., 61, 215.
25. Kelley, S. L., Basu, A., Teicher, B. A., Hacker, M. P., Hamer, D. H., Lazo, J. S. (1988) Overexpression of metallothionein confers resistance to anticancer drugs. Science, 241, 1813.
26. Scheper, R. J., Broxterman, H. J., Sceffer, G. L , Kaaijk, P. Dalton, W. S., van Heljningen, T. H. M., van Kalken, C. K., Slovak, M. L., de Vries, E. G. E , van der Valk, P., Meijer, C. J. L. M., Pinedo, H. M (1993) Overexpression of a Mr 110,000 vesicular-protein in non-P-glycoprotein-mediated multidrug resistance: Cancer Research, 53, 1475.
27. List, A. F., Spier, C. S., Abbaszadegan, M., Grogan, T. M., Greer, J. P., Wolff, S. N., Scheper, R. J., Dalton, W. S. (1993) Non P-glycoprotein (PgP) mediated multidrug resistance (MDR): identification of a novel drug resistance phenotype with prognostic relevance in acute myeloid leukemia (AML). Blood 82 suppl, 1, 1755 (abstract).
28. Fenneteau, O , Marie, J.-P., Lescoeur, B., Vilmer, E., Schlegel, N. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P-170) in acute lymphoblastic leukemia (Letter). Blood 81, 3787.
29. Goasgnen, J. E., Ly Sunnaram, B., Dossot, J.-M., Mordelet, E., Fauchet, R. (1993) Expression of the multidrug resistance-associated P-glycoprotein (P170) in acute lymphoblastic leukemia (Letter). Blood, 81, 3788.
30. Grogan, T. M., Dalton, W. S., Rybski, J., Spier, C., Meltzer, P., Richter, L., Gleason, M., Pindur, J., Cline, A , Scheper, R., Tsuruo, T., Salmon, S. (1991) Optimization of immunohistochemical detection of the multidrug transport protein P170 in human normal tissues and malignant lymphomas. Histopathology, 19, 131.
31. Mannervick, B., Alin, P., Guthenberg, C., Jensson, H., Tahir, M. K., Warholm, M., Jornvall, H. (1985) Identification of three classes of cytosolic transferases common to several mammalian species: correlation between structural data and enzymatic properties. Proc. Natl. Acad. Sci. USA, 82, 7202
32. Wolf, C R., Wareing, D. J., Blask, S., Hayes, J. D. (1990) GST in resistance to chemotherapeutic drugs, in: Hayes, I. D., Pickett, C. B. and Mantle, T. J. (eds): Glutathione-S-transferases and drug resistance. London UK. Taylor and Francis, p295.
33. Clapper, M , Buller, A , Smith, T., Tew, K (1987) GST in alkylating agent resistant cells, in Mantle, T. J , Pickett, C. B. and Hayes, J. D. (eds): Glutathione-S-transferases and carcinogenesis. London UK. Taylor and Francis, p213.
34. Moscow, J. A., Fairchild, C. R., Madden, M. J , Ranson, D. T., Wieand, H S., O'Brian, E. E., Poplack, D. G., Gossman, J., Myers, C. E., Cowan, K H. (1989) Expression of anionic glutathion-S-transferases and P-glycoprotein genes in human tissues and tumors. Cancer Research 49, 1422.
35. Shea, T , Hennet, W. (1987) GST-pi in human rumors, in Mantle, T. J., Pickett, C. B. and Hayes, J. D. (eds). Glutathione-S-transferases and carcinogenesis. London: Taylor and Francis, p227.
36. Tew, K. D. (1989) The involvement of glutathione-S-transferases in drug resistance. in: Tapiero, H., Robert, J., Lampidis, T. (eds): Anticancer drugs. (Colloque INSERM) London UK, Paris F. John Libbey Eurotexte Ltd, INSERM, 191, 103.
37. Tew, K. D., Shisselbauer, M., Clapper, M., Kuzmich, S. (1990) GST and resistance to alkylating agents. in: Hayes, J. D., Pickett, C. B., Mantle, T. J. (eds): Glutathione-S-transferases and drug resistance. London UK. Taylor and Francis, p309.
38. Bahnson, R. R., Basu, A., Lazo, J. S. (1991) The role of metallothioneins in the anticancer drug resistance. Molecular and clinical advances in anticancer drug resistance. Boston MA, Kluwer academic publishers, p251.
39. Karim, M. (1985) Metallothioneins: proteins in search of function. Cell 41, 9.
40. Klug, A., Rhodes, D. (1987) "Zinc fingers": a novel protein motif for nucleic acid recognition. Trends Biochem. Sci. 12, 464.
41. Endressen, L., Bakka, A., Rugstad, H. E. (1983) Increased resistance to chlorambueil in cultured cells with a high concentration of cytoplasmic metallothionein. Cancer Research, 43, 2918.
42. Holmes, J., Wareing, C., Jacobs, A., Hayes, I. D., Paduar, A., Wolff, C. R. (1990) GST-pi expression in leukemia: a comparative analysis with MDR-1 data. Br. J. Cancer, 62, 209.
43. McQuaid, S., Mc Cann, S., Daly, P., Lawlor, S., Humphries, P. (1989) Observations of the transcriptional activity of the GST-pi gene in human haematological malignancies and in the peripheral leukocytes of cancer patients under chemotherapy. Br. J. Cancer, 50, 540.
44. Koberda, J., Hellmann, A. (1991) GST activity of leukemic cells as a prognostic factor for response to chemotherapy in acute leukemias. Med. Oncol. an Tumoi pharmacoter., 8, 35.
45. Teicher, B. A., Holden, S. A., Kelley, M. J., Shea, T. C., Cucchi, C. A., Rosowsky A. Henner, W. D., Frei, E. (1987) Characterization of a human squamous carcinoma cell line resistant to cisdiaminedichloroplatinium. Cancer Research, 47, 388.
46. Andrews, P A., Murphy, M. P., Howell, S. B. (1987) Metallothionein mediated cisplatin resistance in human ovarian carcinoma cells. Cancer Chemother. Pharmacol., 19, 149.
47. Webber, M. M., Maseehur, Rehman, S. M., James, G. T. (1988) Metallothionein induction and deinduction in human prostatic carcinoma cells; relationship with resistance and sensitivity to adriamycin. Cancer Research, 48, 4503.